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KEY POINTS 
 
 In the year before bereavement, partners of the deceased with dementia were more 
likely to be diagnosed with depression and receive psychotropic medication than 
partners from bereavements without dementia.   
 After bereavement, partners of the deceased with dementia were less likely to 
initiate psychotropic medication, and were more likely to be alive at one year, than 
partners from bereavements without dementia. 
 Prior to the bereavement, subjects who died with dementia were less likely to 
receive palliative care.  
 Services need to address the needs of carers for individuals dying with dementia 
prior to the bereavement, and improve access to palliative care. 
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ABSTRACT 
OBJECTIVE: Caring for a partner with dementia and partner bereavement are independently 
associated with poor health.  An understanding of the health effects of living with a partner 
dying with dementia can help optimise support.  We describe health in the year before and 
after loss of a partner with dementia compared to other bereavements. 
METHODS: In a UK primary care database, 2624 older individuals whose partner died with 
dementia during 2005-2012 were matched with 7512 individuals experiencing bereavement 
where the deceased partner had no dementia recorded.  
RESULTS: Prior to bereavement, partners of the deceased with dementia were more likely 
to be diagnosed with depression (OR 2.31, 1.69-3.14) and receive psychotropic medication 
(OR 1.34, 1.21-1.49) than partners from bereavements without dementia.  In contrast, 
psychotropic medication initiation two months after dementia bereavement was lower (HR 
0.69, 0.56-0.85). Compared to other bereaved individuals, mortality after bereavement was 
lower in men experiencing a dementia bereavement (HR 0.68 (0.49-0.94) but similar in 
women (HR 1.02, 0.75-1.38). Prior to bereavement, those who died with dementia were less 
likely to receive palliative care (OR 0.47, 0.41-0.54). 
CONCLUSION: In the year before bereavement, partners of individuals dying with dementia 
experience poorer mental health than those facing bereavement from other causes and 
their partner is less likely to receive palliative care. In the year after, individuals whose 
partner died with dementia experience some attenuation of the adverse health effects of 
bereavement. Services need to address the needs of carers for individuals dying with 
dementia and improve access to palliative care.  
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1 Introduction 
Caring for a partner with physical or mental disability is associated with an increased risk of 
health problems(Schulz and Beach, 1999, Roth et al., 2009). These adverse effects are 
primarily reported in those with high levels of caregiver strain and carers for partners with 
dementia have been identified as experiencing higher levels of strain and health problems 
than other carers(Schulz and Beach, 1999, Roth et al., 2009, Ory et al., 1999, Pinquart and 
Sorensen, 2003b).  
 
Bereavement is a well-established risk factor for poor psychological and physical health with 
an increased risk of death, cardiovascular events, depression and psychotropic medication 
use in the year after death of a partner(Stroebe et al., 2007, Moon et al., 2011, Carey et al., 
2014, Shah et al., 2013c). However, analysis of routine data suggests that the subsequent 
mortality effect is absent in those whose partner dies of dementia(Elwert and Christakis, 
2008). One possible explanation for this is that the pre-death grief associated with caring for 
a partner with dementia(Lindauer and Harvath, 2014), may result in many detrimental 
effects to health being realised prior to the point of bereavement, leaving no additional 
mortality risk burden afterwards. Two small studies of dementia caregivers have identified 
high levels of depressive symptoms in the year before death of a partner with a reduction in 
symptoms after bereavement, along with a reported sense of relief for a majority of 
dementia caregivers(Schulz et al., 2001, Schulz et al., 2003). These findings suggest that any 
increases in providing support would have the greatest benefit to caregivers immediately 
prior to the bereavement. However, the difficulty of identifying a terminal phase of the 
disease process for dementia as compared to say cancer, means many people with 
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dementia may experience poorer access to end of life care which may limit opportunities to 
support partners both before and after bereavement (Sachs et al., 2004). 
 
In this study, we use data from a large English primary care database to test the hypothesis 
that the effect on mental health, measured by a clinical diagnosis of depression and use of 
psychotropic medication, in the year before bereavement differs between those whose 
partners die with a diagnosis of dementia and others experiencing bereavement. We also 
examine whether access to palliative care before bereavement and the health impact of 
bereavement, measured by initiation of psychotropic medication and risk of death in the 
first year after bereavement, differ between these groups. Understanding these differences 
is important in developing and targeting appropriate support for carers of people with 
dementia. 
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2 Methods 
2.1 Data source 
The Health Improvement Network (THIN) is an established primary care database which 
collects anonymised data from United Kingdom (UK) primary care (family) practices. It 
includes a full record of diagnoses and prescribing, and has been shown to be 
demographically representative of the UK(Lewis et al., 2007, Blak et al., 2011). A feature of 
the THIN database is the family number which allows practices to identify patients who live 
in the same household(Shah et al., 2010).   
 
2.2 Identification of Couples 
Out of 495 practices providing data to the THIN scheme at study inception in 2010, we 
included all 401 practices active in the scheme between 2005 and 2008 which provided data 
for at least one year. We have previously described how we used historically collected data 
to determine retrospective composition of households between 2005 and 2008 for all 
registered patients aged 60 and over (Shah et al., 2012). This allowed us to determine an 
index date for each couple.  
We based our approach to identification of cohabiting couples on an analysis of national 
survey data(Office for National Statistics 2005). This showed among those aged 60 and over, 
couples of the opposite sex living together in a household with less than ten years age 
difference are almost invariably (99.4%) married or cohabiting(Shah et al., 2012). We 
developed an algorithm which identified households that contained an older person aged 60 
and over living with another adult aged 50+ years of opposite sex(Shah et al., 2012). We 
required included couples to have an age difference of ten years or less, and that no 
younger adult in the household be within 15 years of either of the couple. Couples where 
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either member had a record of residence in institutional care settings were excluded.  This 
approach identified 171,720 eligible couples(Shah et al., 2012). 
 
2.3 Bereavement 
Couples were followed in the primary care record from their index dateto their last practice 
data collection date up to September 2012. When one or both members of the couple 
deregistered from the participating general practice, both members of the couple were 
censored from the analysis at that point. The timing of bereavement was identified through 
the record of death in the deceased partner’s primary care record. 35,872 older people 
(21% of couples) experienced bereavement during follow up.  
2.4 Dementia Bereavement 
We identified 2688 individuals who experienced a bereavement where their deceased 
partner had a diagnosis of dementia and who were registered with their GP for at least one 
year before the bereavement. 
2.5 Matched Non-Dementia Bereavement Group 
We identified an age (within 5 years at bereavement), sex and practice matched control 
group of individuals who experienced bereavement where their deceased partner had no 
record of a diagnosis of dementia. We required that their date of bereavement was within 
three years of the index patient with dementia bereavement.  Up to three controls (n=7512) 
were identified, with 2624 (98%) dementia bereavements matched with at least one non-
dementia bereaved control (Figure 1).  
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2.6 Outcomes 
2.6.1 Year before Bereavement 
We identified any diagnosis of depression in the year before bereavement in the primary 
care record by electronically searching for diagnostic codes for depression which are 
included in the UK Quality and Outcomes Framework (QOF)(General Medical Services 
Contract, 2015). QOF is a national pay for performance primary care incentive system in the 
UK which defines nationally agreed disease codes and standards of care for chronic 
conditions.  
For psychotropic prescribing, we identified any prescription for anxiolytics, hypnotics, 
antidepressants and antipsychotics in the primary care record. Low dose amitriptyline 
(<50mg) prescribing was excluded as, in the UK, low dose amitriptyline may be prescribed 
for pain management.  
We also identified whether the deceased partner had been identified as needing palliative 
care prior to their death. This was based on whether they had a Read code indicating 
inclusion on the palliative care register for the practice for the Quality and Outcomes 
framework(General Medical Services Contract, 2015).  
2.6.2 Year after Bereavement  
Analyses of psychotropic drug initiation were restricted to 1,938 patients with dementia 
bereavements who had not received any psychotropic medication prescriptions in the year 
before the bereavement. We created new matchsets for these 1,938 dementia 
bereavements (Figure 1), now matched on age, sex and practice as before plus no receipt of 
any psychotropic in the year before the bereavement, in individuals who experienced 
bereavement without a diagnosis of dementia in their partner’s record. This resulted in 
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1883 dementia bereavements being successfully matched with 5331 patients experiencing 
non-dementia bereavement who had not received any psychotropic medication in the year 
before their bereavement date.  
We also identified death of the bereaved individual in the first year after bereavement. 
 
2.6.3 Contact with Primary Care 
Contact was measured as contact days which were defined as the number of days on which 
there was a record of contact with primary care excluding administrative events(Shah et al., 
2013a). This was assessed in both the year before and after bereavement. 
 
2.7 Analysis 
Analyses were carried out using both SAS version 9.2 (SAS Institute, Inc., Cary, North 
Carolina) and Stata version 13.0 (StataCorp). We adjusted all comparisons for the following: 
age (as a continuous variable, to account for small disparities post matching), comorbidity 
(using the Charlson Index(Khan et al., 2010) in categories of 0, 1, 2-3, 4+), smoking status 
(never, ex, current or unknown), year of bereavement (2007/8, 2009/10, 2011/2) and socio-
economic status (using quintiles of the Townsend area deprivation score(Townsend et al., 
1988)).  
For dichotomous outcomes (depression diagnosis, receipt of psychotropic medication in the 
year before bereavement, palliative care) a conditional logistic model was used and results 
are presented as odds ratios.  
For medication initiation in the year after bereavement, we present Kaplan-Meier estimates 
of the probability of bereaved individuals receiving a new first prescription of each class of 
drug in the two and twelve months after bereavement with individuals censored from the 
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analysis on death or deregistration(Shah et al., 2013c). We also present hazard ratios for 
initiation based on a Cox proportional hazards survival model, stratified by matchset.  
For mortality after bereavement, a Cox proportional hazards survival model, stratified by 
match sets was used. For analyses for contact with primary care, a conditional Poisson 
model was used, with an offset that accounts for patients with less than one year follow up 
time(Carey et al., 2014). 
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3 Results 
3.1 Characteristics of Groups 
The baseline characteristics of the dementia bereavement and the non-dementia 
bereavement comparison group are summarised in Table 1. The dementia bereavement 
group was slightly older than the non-dementia bereavement group with a mean age of 
80.4 compared to 79.6. Otherwise, the two groups were similar in their smoking status, co-
morbidity scores and area deprivation.  
 
3.2 Depression Diagnosis and Medication Use in the Year before Bereavement 
In the year before bereavement, 83 (3.2%) patients whose partner had a diagnosis of 
dementia received a diagnosis of depression compared to 116 (1.5%) whose partner did not 
have a diagnosis of dementia (OR 2.31, 1.69-3.14).  A similar pattern was seen when the 
outcome was restricted to a new diagnosis, defined as a patient without a diagnosis of 
depression in the year preceding the index depression diagnosis (Table 2).  
722 (27.5%) of the dementia bereavement group received a prescription for a psychotropic 
drug in the year before bereavement compared to 1664 (22.2%) of the non-dementia 
bereavement group (OR 1.34, 1.21-1.49). This difference was seen separately for 
antidepressant (OR 1.52, 1.33-1.72) and anxiolytic/hypnotic (OR 1.15, 1.01-1.31) medication 
(Table 2). Gender stratified analysis did not modify our findings. 
 
3.3 Receipt of Palliative Care 
341 (13.0%) deceased partners with dementia received palliative care in the year before 
death compared to 1772 (23.6%) of partners who died without a diagnosis of dementia. The 
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odds ratio for receipt of palliative care for those with a diagnosis of dementia was 0.47 (0.41 
to 0.54) compared to those dying without a diagnosis of dementia (Table 2). 
 
3.4 Contact with Primary Care  
Contact with primary care, summarised as average number of days before and after the 
bereavement is shown in Table 3. In the year before bereavement, those experiencing a 
dementia bereavement had slightly higher levels of contact with primary care compared to 
the non-dementia bereavement group with a mean 9.46 contact days compared to 8.96 (RR 
1.04, 1.00-1.08). In the year after bereavement, contact for both groups increased to 11.60 
and 11.39 respectively with attenuation of the difference between the groups (RR 1.00, 
0.97-1.04). 
 
3.5 Psychotropic Medication Initiation after Bereavement 
In the year after bereavement, the risk of starting a new psychotropic medication was 15.0% 
for those experiencing dementia bereavement compared 18.2% in the non-dementia 
bereavement group (table 4). The adjusted hazard ratio for initiation among those 
experiencing a dementia bereavement was 0.81 (0.70-0.94) compared to the non-dementia 
bereavement group. Initiation in the first two months after bereavement showed a more 
marked difference with the hazard ratio for the dementia bereavement group being 0.69 
(0.56-0.85). Analysis by drug type suggested the differences between the two bereavement 
groups was primarily explained by differences in anxiolytic and hypnotic prescribing in the 
first two months after bereavement (Table 4).  
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3.6 Mortality after Bereavement 
Comparison of mortality experience between the two bereaved groups suggested a trend 
toward lower mortality in the dementia bereavement group (HR 0.84, 0.68-1.05) (Table 5). 
Analysis stratified by gender showed a lower mortality in men experiencing dementia 
bereavement (HR 0.68, 0.49-0.94) but not women (HR 1.02, 0.75-1.38). However, a test for 
heterogeneity of effect between men and women was not significant (P=0.08). 
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4 Discussion 
We have identified that older people living with a partner with dementia experience higher 
levels of depression and psychotropic medication use in the year before bereavement than 
others facing bereavement, and their partner is less likely to receive palliative care.  In the 
year after dementia bereavement, new use of psychotropic medication is lower in those 
experiencing dementia bereavement than in those experiencing other bereavement and 
mortality is lower in men experiencing dementia bereavement. 
 
4.1 Strength and Limitations 
We have been able to describe key outcomes in a large unselected population of older 
people whose partner dies with dementia. The design of our study allows wider 
generalizability of our pre-bereavement findings which may not be possible in studies which 
recruit individuals based on expectation of death of a partner.  
Our use of routine medical records leads to a number of potential limitations. Firstly, we 
identified couples indirectly through a marker of cohabitation in the primary care record. 
However, we confirmed the validity of this approach by comparison with contemporary 
national representative household surveys in England, which confirmed that 99.4% of 
couples selected using our criteria identify themselves as married or cohabiting(General 
Household Survey, 2005, 2007).  
Secondly, our dementia bereavement group will include individuals whose partners have a 
wide range of severity of dementia, including those where dementia was a comorbidity, 
rather than the main health problem in the last year of life. However, the main effect of this 
potential misclassification would be to reduce differences between the dementia and non-
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dementia bereavement groups, and would therefore not explain our findings. In addition, 
our findings are more likely to be generalizable to the mix of patients living with dementia in 
the community.  
Thirdly, our outcomes relied on either a recorded diagnosis in primary care or prescribing 
decisions by clinicians.  These codes or decisions will not be standardised across different 
practices, and are thus subject to more variation compared to objective assessments of 
mental health using standardised questionnaires. This has likely resulted in an 
underestimate of the prevalence depression overall, but the matched design in our study 
ensures that all comparisons are within practice, minimising the effect of between practice 
variations in diagnosis and prescribing. However, we cannot exclude the possibility that 
diagnosis or prescribing is biased by the clinician’s knowledge that an individual’s partner 
suffers from dementia. Nor can we discount that the greater primary care contact prior to 
bereavement for those with dementia partners, increased the likelihood of diagnosis, have 
overestimated the true underlying difference. However, the more than doubling of the rate 
of recorded diagnosis seems unlikely to be explained by the far small (4%) difference in 
primary care contact we estimated. After bereavement, we chose to report only on 
prescribing outcomes, as we believe that this approach is preferable as it avoids concerns 
over variations in diagnostic recording and coding between clinician related to knowledge of 
a recent bereavement and potential confusion between grief and depressive symptoms.  
Fourthly, we were not able to characterise the caregiving role of those experiencing 
bereavement and level of care-giver strain experienced.  Previous work has identified that 
those experiencing high levels of care-giver strain are the most vulnerable to adverse health 
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effects(Schulz and Beach, 1999, Roth et al., 2009). This means that our results are likely to 
underestimate the health effect on those with the greatest care-giving burden. 
Finally, although we were unable to adjust for individual socioeconomic markers, 
neighbourhood indicators of socioeconomic deprivation, such as the Townsend score, have 
been shown to be acceptable proxies(Adams et al., 2005).  
4.2 Context 
Our finding of higher levels of depression and psychotropic medication use in the pre-
bereavement period for people living with partners with dementia is consistent with the 
literature that caring for an individual with cognitive impairment has a greater impact on 
mental wellbeing than caring for an individual with physical health problems(Ory et al., 
1999, Pinquart and Sorensen, 2003b, Tooth et al., 2008).     
Our findings also support the concept of a pre-bereavement impact on health as both 
bereavement groups experienced high utilisation of psychotropic medication in the year 
before bereavement. A recent study using the Health and Retirement Survey in the United 
States, demonstrated poorer health measures, including increased depressive symptoms, in 
those experiencing widowhood in the two years after assessment(Vable et al., 2015).   
In interpreting our findings in the year after bereavement, it should be noted that all 
comparisons are with a bereaved group. We have established, in previous work in the same 
dataset, that the year after bereavement is associated with higher levels of mortality and 
psychotropic medication use(Shah et al., 2012, Shah et al., 2013c). This means our finding of 
lower mortality and psychotropic use for individuals experiencing dementia bereavement 
must be interpreted as an attenuation of the impact of bereavement and not an absolute 
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protective effect compared to non-bereaved individuals. This was confirmed in a 
supplementary analysis (details available upon request) which compared the dementia 
bereaved group with a matched non-bereaved group, and showed no evidence of increased 
risk of death in the first year (HR=0.98, 95% 0.79-1.22).. 
The attenuation of the rise in mortality in bereaved men whose partner died with dementia 
is consistent with findings of a United States Medicare based study(Elwert and Christakis, 
2008). They found the only causes of death where there was no significant increase in risk of 
death for the bereaved spouse was when the deceased spouse died from Alzheimers or 
Parkinsons disease.  Our work confirms and extends this finding. 
4.3 Interpretation 
Although caregiving is conventionally identified as deleterious to health, evidence suggests 
that the effects of caregiving are more complex and determined by both the strain 
associated with care giving and the nature of the condition which leads to the care 
need(Roth et al., 2013, Fredman et al., 2009, Pinquart and Sorensen, 2003a). Our findings 
demonstrate that the impact of living with a person with dementia in their last year of life 
differs from other conditions. A potential explanation for this difference is that living with a 
person with dementia may not offer some of the psychological benefits of a caring 
role(Pinquart and Sorensen, 2003a).  
A potentially worrying finding in our study is that people dying with dementia were less 
likely to receive palliative care than individuals dying with other conditions. Palliative care is 
relatively well developed in the UK with hospital and community based teams working 
together with hospices. Patients may be referred by hospital or community physicians 
((including general practitioners) and nurses, and in many cases self-referrals are accepted. 
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There are no restrictions on the types of terminal condition accepted for care, however t 
our findings reinforce concerns over access to palliative care for people with dementia, and 
may reflect a number of potential access barriers(Sachs et al., 2004, Birch and Draper, 
2008)1. These include perceived difficulty in predicting the timing of death and also 
availability of palliative care services which are suitable for people with dementia. However, 
palliative care is an opportunity to offer practical and psychological support to carers and 
this may mean that dementia carers, with the highest levels of need, are not able to access 
this support. In addition, there is some evidence that palliative care improves partner health 
outcomes after bereavement(Christakis and Iwashyna, 2003). We noted that uptake of 
palliative care was low overall, perhaps because our comparison group included individuals 
who died unexpectedly where palliative care would not normally be offered.   
Our finding that the effects of bereavement on health are less marked where the partner 
dies with dementia may be explained by a number of mechanisms. This may partly reflect 
pre-bereavement health effects where both psychological and physical illness occurs before 
bereavement(Vable et al., 2015). High levels of anticipatory grief are reported before 
bereavement in dementia carers and this is associated with pre-bereavement 
depression(Vable et al., 2015). This may mean that individuals who survive their partner 
with dementia are healthier than other bereaved individuals. As well as selection effects, 
the experience of grief after bereavement due to dementia is known to be different with 
relief reported by the majority of carers(Schulz et al., 2003). This may explain the lower 
immediate use of anxiolytics after bereavement where the partner dies with dementia. 
Indeed, improvement in health-related behaviours has been reported after dementia 
bereavement(Schulz et al., 2003).   
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Our work further challenges the assumption that the health effects of bereavement are an 
immutable consequence of grief and demonstrate how the effects of bereavement are 
modified by the circumstance of death(Shah et al., 2013b).  This is reinforced by the 
potential gender differences in the effect of dementia bereavement on mortality with the 
attenuation in mortality rise restricted to men. This may reflect different gender roles for 
carers and needs further confirmation and exploration. Overall our findings highlight the 
potential for appropriate interventions to modify the health effects of bereavement and the 
need to support bereaved individuals before death of a partner. 
It is important to reiterate that the experience of bereavement due to dementia attenuates 
but does not remove the effect of bereavement on health. In addition, dementia 
bereavement will be a heterogeneous experience for different individuals and some will be 
at risk of severe grief reactions which may be partly predicted by circumstances before 
death(Schulz et al., 2006). 
In conclusion, our work highlights the vulnerability of individuals living with a partner with 
dementia in the period before bereavement and the need for health and social care services 
to respond to this need. Specifically, improving access to palliative care for people with 
dementia may be an important intervention to improve the health of carers as well as the 
wellbeing of people living with dementia. 
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Table 1: Characteristics of bereaved partner by whether the deceased had a diagnosis of 
demenita 
 Bereaved 
Characteristic 
Deceased Partner 
With Dementia 
Deceased Partner 
Without Dementia  
 n % n % 
     
Total  2,624 100% 7,512 100% 
     
Gender     
- Male 965 37% 2,673 36% 
     
Age at bereavement*     
- 55-69 167 6% 534 7% 
- 70-84 1,716 65% 5,190 69% 
- 85- 741 28% 1,788 24% 
     
Year of bereavement     
- 2005-08 1,059 40% 3,321 44% 
- 2009-12 1,565 60% 4,191 56% 
     
Smoking status     
- Non 1,289 49% 3,557 47% 
- Ex 967 37% 2,925 39% 
- Current 287 11% 837 11% 
- Missing 81 3% 193 3% 
     
Townsend     
- 1 (least deprivation) 708 27% 2,037 27% 
- 2 665 25% 1,884 25% 
- 3 541 21% 1,554 21% 
- 4 447 17% 1,207 16% 
- 5 (most deprivation) 194 7% 662 9% 
- Missing 69 3% 168 2% 
     
Charlson Score     
- 0 1,067 41% 3,054 41% 
- 1 637 24% 1,923 26% 
- 2 to 3 669 26% 1,989 26% 
- 4 or more 251 10% 546 7% 
     
 
* Mean age was 80.4 years (SD=6.6) for bereaved with Deceased Partner with Dementia, and 79.6 years 
(SD=6.5) for bereaved with Deceased Partner without Dementia.  
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Table 2: Depression diagnosis, psychotropic medication prescribing and partner access to 
palliative care in the year before bereavement in bereaved partners 
 
Outcome  Bereaved 
 
 
 
  Deceased Partner 
With Dementia  
N=2,624 
 Deceased Partner 
Without Dementia  
N=7,512 
Depression diagnosis  N 83 116 
 % 3.2% 1.5% 
 OR† 2.31 (1.69-3.14) 1  
    
New diagnosis only* N 73 102 
 % 2.7% 1.4% 
 OR† 2.37 (1.69-3.32) 1  
    
Any Psychotropic N 722 1,664 
 % 27.5% 22.2% 
 OR† 1.34 (1.21-1.49) 1  
    
Antidepressant N 448 925 
 % 17.1% 12.3% 
 OR† 1.52 (1.33-1.72) 1  
    
Hypnotic/Anxiolytic  N 398 1,004 
 % 15.2% 13.4% 
 OR† 1.15 (1.01-1.31) 1  
    
Palliative Care  N 341 1,772 
(offered to  partner) % 13.0% 23.6% 
 OR† 0.47 (0.41-0.54) 1  
 
*No diagnosis in the year preceding the index diagnosis 
†Adjusted for age (bereavement), Townsend, Smoking, Charlson and Year of Bereavement.  
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Table 3: Contact with primary care in the year before and after bereavement in bereaved 
partners 
 
  Year Before Year After† 
   Deceased 
Partner With 
Dementia  
N=2,624 
 Deceased 
Partner 
Without 
Dementia  
N=7,512 
 Deceased 
Partner With 
Dementia  
N=2,624 
 Deceased 
Partner 
Without 
Dementia  
N=7,512 
      
Contact days per year  Mean 9.46 8.96 11.60 11.39 
 s.e. 0.17 0.09 0.23 0.13 
      
 RR* 1.04  
(1.00-1.08) 
1  1.00  
(0.97-1.04) 
1 
 
*Adjusted for age (bereavement), Townsend, Smoking, Charlson and Year of Bereavement.  
†Number of days registered after bereavement fitted as offset in model to account for varying time at risk. 
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Table 4:  Psychotropic medication initiation rates and hazard ratios for initiation of 
psychotropic medication in the first two and twelve months after bereavement for 
bereaved partners 
 
Drug Group 
Months 
after 
bereave-
ment 
 Deceased Partner 
With Dementia  
N=1,883 
 Deceased Partner 
Without Dementia  
N=5,331 
Dementia vs.  
Non Dementia 
Bereavement  
Number 
initiating 
K-M 
Initiation 
Rate 
Number 
initiating 
K-M 
Initiation 
Rate 
Hazard Ratio*  
(95% CI) 
       
All Psychotropics 0-2a 120 6.5% 500 9.5% 0.69 (0.56-0.85) 
 0-12b 259 15.0% 910 18.2% 0.81 (0.70-0.94) 
       
Antidepressants 0-2a 25 1.4% 88 1.9% 0.77 (0.49-1.21) 
 0-12b 111 6.8% 317 8.6% 0.79 (0.64-0.98) 
       
Hypnotics/ Anxiolytics 0-2a 96 5.1% 431 8.2% 0.63 (0.50-0.79) 
 0-12b 174 9.9% 634 12.5% 0.77 (0.65-0.92) 
       
 
a-60 days, b- 365 days 
*Adjusted for age (bereavement), Townsend, Smoking, Charlson and Year of Bereavement 
  
 
 
28 
 
Table 5: Mortality in the first year after bereavement for bereaved partners 
   Deceased Partner 
With Dementia  
N=2,624 
 Deceased Partner 
Without Dementia  
N=7,512 
    
All    
Number of Deaths n 129 389 
 % 4.9% 5.2% 
Adjusted Model* HR (95% CI) 0.84 (0.68-1.05) 1 (Baseline) 
    
Women     
Number of Deaths n 73 188 
 % 4.4% 3.9% 
Adjusted Model* HR (95% CI) 1.02 (0.75-1.38) 1 (Baseline) 
    
Men     
Number of Deaths n 56 201 
 % 5.8% 7.5% 
Adjusted Model* HR (95% CI) 0.68 (0.49-0.94) 1 (Baseline) 
    
 
Note: Status at the end of one year for the following groups was - Deceased Partner with Dementia: Still registered 
(n=1,935, 73.7%), De-registered (n=112, 4.3%), Dead (n=129, 4.9%), Has less than 1 year of practice follow up (n=448, 
17.1%); Deceased Partner without Dementia: Still registered (n=5,681, 75.6%), De-registered (n=411, 5.5%), Dead (n=389, 
5.2%), Has less than 1 year of practice follow up (n=1,031, 13.7%) 
*- Adjusted for age (bereavement), Townsend, Smoking, Charlson and Year of Bereavement. 
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Figure1: Summary of Matchsets 
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